Forecast data for Penicillins and Streptomycins dosage market in Brazil indicates an ascending trajectory from 2024 to 2028, starting at $457.66 million in 2024 and reaching $479.85 million by 2028. This forecast implies a general yearly growth. Previous actual data for 2023 shows the market value stood at $452.05 million. Year-on-year variation percentages between 2024 and 2028 show incremental increases, underlining a steady, albeit modest, market expansion. The Compound Annual Growth Rate (CAGR) over the 5-year period averages approximately 1.44%.
Future trends to watch include increased demand due to rising healthcare needs, potential breakthroughs in antibiotic resistance, and market competition from newer antibiotic classes. Monitoring regulatory changes and healthcare policies in Brazil will also be crucial for these forecasts.
